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USP <800> Hazardous Drug Compliance
Abstract
Problem: United States Pharmacopeia (USP) developed a set of standards to minimize exposure
risks to patients, healthcare workers, and the environment when preparing, handling, and
administering hazardous drugs (HDs) known as USP <800> HDs. The guidelines became
effective December 1, 2019, but additional information is needed to ensure healthcare personnel
are complying with the standards.
Context: Two medical surgical units from Hospital A were included in this project. Currently
mandatory online modules about USP <800> standards are provided annually to every healthcare
worker, but it is unknown if the policies and procedures are being followed appropriately.
Interventions: Active and passive observations as well as inspections were used to compile data
regarding the compliance of USP <800> standards of both healthcare workers and within the
hospital setting. Surveys were conducted through informal ‘elbow-to-elbow’ interviews with
hospital employees, primarily nurses, to collect subjective evidence.
Measures: The measures can be divided into two categories: personnel and atmosphere
compliance. Measures to determine personnel compliance include determining a current level of
knowledge and comfortability, collecting self-reported compliance to the standards, and
observing personal protective equipment (PPE) donning and doffing techniques. Atmosphere
compliances are measured by calculating the total number of patients taking USP <800> HDs,
evaluating the accuracy and efficiency of notifications in the electronic health record (EHR),
documenting the frequency of correctly displayed signage on patient doors, and assessing
supplies located on USP <800> carts.
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Results: Nurses self-reported a high level of knowledge and comfortability regarding safe
handling and administration practices of USP <800> HDs. However, despite over a quarter of
the patients being on at least one USP <800> drug, compliance with proper PPE
recommendations, signage, and accessibility of supplies was low.
Conclusions: This project determined that healthcare employees at Hospital A are not
consistently following the recommended USP <800> standards. It also provided a baseline
knowledge for future education to ensure safety of patients, healthcare employees, and the
environment.
Keywords: USP <800> policy, hazardous drugs, hazardous medication, nursing, safety
standards, and personal protection equipment (PPE)
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Section II: Introduction

Problem Description
The United States Pharmacopeia (USP) organization began over 200 years ago in 1820
with a goal to improve public health specifically overseeing poor-quality European drugs
deemed “good enough for America” (USP Timeline: Building trust for over 200 years: A
timeline of USP, n.d.) . It also regulated medications and doses given by local apothecary’s and
other nonconventional medical healers (From Guesswork to Standards: The History of Medicine
Quality, n.d.). This non-profit organization consisted of a small group of physicians who
established the first set of medication standards (From Guesswork to Standards: The History of
Medicine Quality, n.d.) providing reliable information about proper high-quality care for sick
and wounded patients (USP Timeline: Building trust for over 200 years: A timeline of USP, n.d.).
The Pure Food and Drug Act of 1906 declared USP guidelines as standard regarding the purity,
strength, and quality of medical drugs and as such, all medicines were expected meet the
appropriate standards (USP Timeline: Building trust for over 200 years: A timeline of USP, n.d.).
By 1969, the USP organization had begun to collaborate with other countries around the world
and today 140 countries follow USP standards (USP Timeline: Building trust for over 200 years:
A timeline of USP, n.d.).
In 1970, two U.S. federal agencies were established to endorse safe and healthy work
environments and to eliminate occupational-related health risks: the National Institute for
Occupational Safety and Health (NIOSH) created as part of the Centers for Disease Control and
Prevention (CDC) and the Occupational Safety and Health Administration (OSHA) formed
under the U.S. Department of Labor (About NIOSH, 2022). In 1981, NIOSH released an article
cautioning about the exposure risks of certain antineoplastic drugs with recommendations that
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the medications be prepared in a safety cabinet to reduce risks (Zimmerman et al., 1981). Later
in 1995, OSHA expanded the definition of this class of medications to “hazardous drug” to
include a greater range of medications with potentially harmful effects and released guidelines
but not mandatory standards including proper personal protective equipment (PPE) usage (Zhao
& Radwick, 2020). It was not until 2004 that NIOSH advised about the importance of hazardous
drug (HD) safe handling from preparation to administration as well as the potential exposure risk
to the patient, healthcare workers, and the environment including medication waste and the
patient’s waste (Zhao & Radwick, 2020). Eventually in 2010 the first list of HDs was released
which has been updated five times in 2012, 2014, 2016, 2018, and 2020 (Zhao & Radwick,
2020).
Despite multiple government and private agencies acknowledging and researching the
risk of HDs to the patient, the healthcare workers, and the environment, it was not until 2014 that
USP proposed a distinct set of guidelines (Zhao & Radwick, 2020). This quality standard became
known as USP General Chapter <800> and encompasses healthcare professional responsibilities
including PPE; facility obligations such as personnel training requirements; a set hazard
procedure for spill mitigation including neutralizing and cleaning protocols; and appropriate
documentation (USP 800 | USP, n.d.). The goal of USP <800> guidelines is to protect those who
may have access or exposure to HDs including the patient and those who store, prepare,
transport, and administer the medications (USP 800 | USP, n.d.) and to promote a safe work
atmosphere for the patient, the worker, and the environment (Gabay, 2014). Healthcare personnel
includes (but is not limited to) physicians, physician assistants, home health workers, nurses,
nursing assistants, technicians, pharmacists, specialists such as physical therapists, housekeeping,
and maintenance workers.
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NIOSH continues to update the HD list as new information about drugs are available.
There are currently over 200 drugs on the USP <800> list (Hazardous Drugs- Handling in
Healthcare, n.d.). These drugs can cause acute symptoms like nausea, vomiting, and hair loss or
can pose a chronic threat with potential to cause one or more of the following with exposure:
carcinogenicity, genotoxicity, mutagenicity, teratogenicity, organ toxicity, reproductive toxicity,
or other harmful effects (Andrews & Dill, 2018). The USP <800> drugs are categorized based on
type of risk: hazardous, hazardous: limited risk, or reproductive toxin depending on the
medication, route, and dose administered. Most of the HDs alter or damage DNA (such as
chemotherapy agents) but some HDs change the DNA synthesis process (such as antivirals or
antibiotics) changing the growth or proliferation of healthy cells in a patient or offspring (Connor
et al., 2016). The type of medication and possible risk, dosage, drug form, and packaging play a
role in the assessment of the risk as well as the approach that should be taken with exposure.
It is estimated that over eight million healthcare workers have potential exposures to
hazardous medications each year (Gabay, 2014) and studies continue to find worsening health
affects due to these exposures (Tocco, 2015). A 2017 study found that there was a significant
amount of HD residue left on surfaces after chemotherapy treatment (Böhlandt et al., 2017)
indicating an increased risk of exposure though dermal uptake. While this study focused on
outpatient chemotherapy treatments and collected data from the patient’s home, the same
concepts of surface contamination can be applied in the hospital setting. In fact, a 2015 Canadian
study found that many healthcare workers still have considerable amounts of HDs in urine
samples indicating a significant risk of exposure to HDs despite strict protocols (Hon et al.,
2015). It was concluded that personnel who frequently handle HDs and those who do not receive
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proper handling/administration training or do not follow precautions regularly have a higher
level of urine HD concentration, leading to a greater health risk (Hon et al., 2015).
USP <800> standards became effective on December 1, 2019, but many hospital
organizations had difficulty implementing, educating, and maintaining the minimum standards
due to the COVID-19 pandemic that began a few months later in 2020. Not only did the entire
healthcare system shift their focus and efforts to the pandemic, but the PPE shortage also limited
the amount of PPE available to healthcare workers. Now that PPE resources are more readily
available, hospitals are beginning to shift their focus to the implementation of USP <800> policy
and standards. The primary reason for implementing this evidence-based quality improvement
(QI) project was to identify current awareness and compliance of the USP <800> policy in
Hospital A. The QI intervention’s aim was to provide up-to-date knowledge of existing
compliance through active and passive observation and provide proposed recommendations to
Hospital A’s USP <800> Committee on ways to improve compliance.
Available Knowledge
PICOT Question
The following PICOT question was created to guide a literature research strategy for
evidence-based solutions: Among nurses who administer USP<800> HDs, does active
observation with a supplemental questionnaire compared to passive observation with no direct
intervention increase compliance with safe handling of USP <800> HD over thirteen weeks?
Literature Review
An exhaustive search of literature was completed to discover relevant information related
to the PICOT question of this QI project. Databases including Cumulative Index to Nursing and
Allied Health Literature (CINAHL) and PubMed were searched frequently between August 2022
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and November 2022. Keywords utilized in the search included USP <800> policy, hazardous
drugs, hazardous medication, nursing, safety standards, and personal protection equipment
(PPE). A total of 63 articles were found ranging from 2014 to current (2022). Inclusion criteria
was added to include articles in English resulting in 49 articles remaining. The abstracts of the
articles were reviewed, and articles were chosen based on relevance to the project. Eight articles
were evaluated using the John Hopkins Nursing Evidence-Based Practice Research Evidence
Appraisal Tool (Dang, Dearholt, & Ascenzi, 2022), and are included in Appendix A: EvidenceBased Literature Review Table. The eight articles were appraised resulting in three articles as
Level I (Quality A), two articles as Level III (Quality A and B, respectively), and three articles as
Level V (one as Quality A/B and two as Quality C) (Dang, Dearholt, & Ascenzi, 2022).
Summary of Evidence
The recent development of formal guidelines and official standards regarding safe
practices when handling and/or administering USP <800> HDs is due to decades of research and
advancements. Andrews & Dill (2018) report that research on potential hazards of modern
medications began in the 1930s but it was not until 1970 that a medical resident requested a list
of hazards and precautions to use after becoming concerned about toxicity while administering
chemotherapy drugs. After nearly 90 years since first administering HDs like chemotherapy,
standards created by USP became official in 2019 (Andrews & Dill, 2018). The defining criteria
of USP <800> HDs was updated by NIOSH to include any drugs that have the following
negative health effects: carcinogenicity, reproductive toxicity, genotoxicity, teratogenicity, organ
toxicity, or a new medication that has a similar structure of an existing hazardous medication
(Andrews & Dill, 2018). Today there is a wide range of known side effects if exposed to HDs
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including dizziness/lightheadedness, abdominal pain, nausea, vomiting, dermal injury/sore,
infertility, and/or miscarriages (Eisenberg, 2018).
Andrews & Dill (2018) describe the difficulty of accurately identifying exposures as it
can occur anytime between manufacturing the medication to administration. A study by
Böhlandt, Sverdel, and Schierl (2017) inspected the home of thirteen patients for three days after
receiving outpatient chemotherapy and found HD residue on several surfaces in the home
leading to an increased exposure risk to others in the household. A Canadian study by Hon et al.
(2015) analyzed two sets of 24-hour urine samples from 103 employees with eight job titles
including unit clerk, pharmacist, pharmacy receiver, pharmacy technician, porter, nurse,
transport, and “other” encompassing several other professions like volunteers, oncologists, and
dieticians. It was found that even after following proper protocols around HDs, levels of nonmetabolized cyclophosphamide (CP) were found in urine samples of these healthcare workers
(Hon et al., 2015). Even with no known contact to HDs on shift, the unit clerk was found to have
a high level of CP in their urine sample (Hon et al., 2015) indicating that unexpected yet
significant exposure risk can occur from commonly touched surfaces. Hon et al. (2015) also
noted that while there was no correlation discovered between urine CP concentrations and
known HD contact. Healthcare workers who handled HDs regularly or who reported not
receiving proper HD training were found to have a substantially higher CP urine concentration
(Hon et al., 2015). This and several findings suggest that better communication, increased
education, and improved organization management of USP <800> HD standards and protocols
would improve compliance of safe handling and administration and reduce unnecessary
exposures to healthcare workers (Boiano et al., 2014; DeJoy et al., 2017).
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Even when guidelines are established and well-known to hospital staff, standards are not
always followed. Boiano, Steege, and Sweeney (2014) assessed 2069 anonymous surveys and
discovered nearly 1 of every 7 participants did not always wear gloves when administering HDs
despite 95% of the participants reporting they have received HD training in the past. Per this
report, the most common excuse to not wearing proper PPE included “skin exposure was
minimal” and “exposures are inconsequential or so rare that they do not justify their use [of
PPE]” (Boiano et al., 2014). An additional mixed-method study compared subjective and
objective nursing behaviors to determine compliance of HD protocols. Nurses reported a higher
subjective compliance with recommended PPE compared to objective observation by the
observer (Colvin et al., 2016) thus believing nurses are complying with protocols more often
than they actually are (Boiano et al., 2014; DeJoy et al., 2017).
Rationale
The Lewin’s Change Model is known for influencing change both within an individual
and in a group or organization and involves unlearning and relearning behaviors without losing
self-identity (Harris et al., 2018). This model is comprised of three phases: unfreezing, change,
and refreezing (Harris et al., 2018). Unfreezing involves recognizing the issue, ensuring
management support for change, and raising awareness of the concerns among the staff (Hussain
et al., 2018). In this QI project, a lack of compliance of USP standards was noted by Hospital A’s
Quality Improvement Team and presented to the USP <800> committee to increase
understanding of the gap in care. The next step in Lewin’s model is change. This was done using
active and passive observations to detect compliance levels of USP standards and educate staff
about proper techniques as necessary. The final step in the Lewin’s model is refreezing which
entails incorporating the desired change into everyday practice (Hussain et al., 2018). In this
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project, this phase is established once all healthcare workers consistently follow the USP
standards.
The Orem’s Self-Care Deficit Nursing theory was also used to direct this project. Orem’s
Model of Nursing was developed by nurse theorist, Dorothea Orem, who believed fulfilling selfcare behaviors would be the most successful approach to improving larger health outcomes
(Potter et al., 2021). The model was intended to encourage nurses to assist patients in improving
self-care skills with the goal that the patient’s would eventually be able to do it on their own
(Wilkinson et al., 2020) to better the patient’s overall health. However, the theory can be
expanded and used in this QI project. It is the healthcare worker’s duty to protect themselves and
others from unnecessary HD exposures using health promoting behaviors like always wearing
appropriate PPE. A clinical nurse leader (CNL) within the microsystem can help educate and
encourage the proper self-care activities as seen in this QI project.
Specific Aims
The objectives of this project were to determine current practices and nurse
understanding of USP <800> drug handling and administration. The specific aim included
improving nurse compliance among the medical surgical units with safe handling of HDs as
outlined in the Hospital A 2022 HD Safe Handling and Management Updates Training. The
process began with an initial assessment of the microsystem, review of Hospital A’s HD policy
and procedures, and investigation of current and relevant evidence-based nursing research. The
process ended with the implementation of recommendations based on the assessment of the
microsystem, Hospital A's policy and procedures, data collected during the project through
questionnaires and observational data, and feedback from the medical-surgical staff. By working
on this process, it is expected that an increase in compliance of USP <800> HD standards will
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occur including an increased use of USP carts and PPE by 50%, and an increased number of
correctly filled out door signs. This increase is measured by the questionnaires and observation
data collection. It is important to work on this now because:
1. USP <800> HDs pose a health risk to nurses. Therefore, nurses should be trained to
understand the risks and proper techniques to fully protect themselves.
2. Not following or meeting current USP <800> standards of safe handling became an
enforceable regulation in 2019.
3. Nurses who become ill from repeated exposure to HDs will contribute to the nursing
shortage and may increase costs in paid time off or extra hiring.
4. Adequate PPE is now available following the PPE shortage during the COVID-19
pandemic removing this barrier to comply with USP<800> HD recommendations.
Section III. Methods
Context
Microsystem Assessment
According to Harris et al. (2018), change begins within a microsystem and starts with a
microsystem assessment to identify areas of improvement. The first microsystem analysis used
in this project was the 5P Framework (King & Gerard, 2016). A Plan-Do-Study-Act (PDSA)
cycle was then created and initiated to begin a continuous process for improvement (King &
Gerard, 2016).
5 P Framework.
Purpose. The mission statement of a healthcare organization is a formal declaration of
the hospital’s values, morals, and beliefs. Hospital A’s mission statement includes being
committed to better the health of the community using a high level of safe, compassionate,
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patient-centered care (Hospital A, n.d.). A CNL can support the hospital’s mission statement by
identifying processes or patterns within a microsystem that needs amending and assist in creating
and implementing a plan to make appropriate improvements. It was observed at Hospital A that
the hospital staff did not consistently follow the proper protocol when administering HDs. As
such, the purpose of this plan is to determine a baseline of the current understanding and
knowledge of safe handling and administration of USP <800> drugs to limit unnecessary
exposures to the patient and visitors, the healthcare worker, and the environment. This QI project
aims to further Hospital A’s mission of improving patient safety outcomes by increasing the
understanding and standard compliance of USP <800> hazardous medications and improving the
use of USP <800> carts and door signage.
Patients. This project took place on two medical-surgical units that were determined, by
the pharmacy team of the USP <800> hospital committee, to have the highest concentration of
HD administration behind the hematology/oncology units. The hematology/oncology units
require nurses to have additional certifications for medication administration and therefore were
excluded from the project. Both medical-surgical units cared for a range of 28 to 36 patients at a
time. The patients were found to have a wide range of medical diagnoses including active cancer
diagnoses, history of cancers, and infections.
Professionals. The professionals involved in this project primarily included nurses on the
units that care for patients on UPS <800> HDs and are responsible for handling and
administering the medications. Other healthcare workers such as physicians and housekeeping
were also observed or interviewed as additional perspectives in this study.
Process. The processes involved in caring for patient’s on USP <800> HDs require
additional safety precautions depending on the medication. A workflow diagram of the existing
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process can be seen in Appendix B. The nurse first checks the patient’s medication
administration record (MAR) tab in the electronic health record (EHR) and determines the
appropriate medication to administer. The nurse prepares, handles, administers, and discards the
medication using appropriate PPE noted in the MAR and on the medication label using proper
donning and doffing practices (see Appendix C). To ensure all staff and visitors know about the
extra precautions needed to reduce the potential risk of HD exposure, it is protocol to place
identification signs on the patient’s room door (see Appendix D) and bathroom door (see
Appendix E) containing information about what PPE is required for safety. Finally, the supplies
used in this process are stored in a specific USP <800> cart located on each unit. The supplies
must be restocked frequently to ensure proper use of the cart.
Patterns. Despite the additional PPE requirements, each patient is cared for with highquality patient-centered care. Although nurses reported a high understanding and knowledge of
proper HD safety and administration practices, it was observed using active and passive
observation that proper PPE protocols were not consistently being followed by hospital staff. It
was also found that USP <800> carts were not stocked with appropriate supplies and appeared to
not be used during the data collection period.
Strengths, Weaknesses, Opportunities, and Threats (SWOT) Analysis. After
thoroughly assessing the microsystem using the 5 P’s framework, it is important to determine
various objective factors that can cause positive or negative effects on the project (King et al.,
2021, p 179). This can be done using a SWOT analysis which helps with strategic planning for
possible solutions to existing threats within the microsystem (King et al., 2021, p 179). See
Appendix E for the full SWOT Analysis diagram.
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Strengths and Weaknesses. Practices already implemented and used within the
microsystem that contribute to the desired goal are considered “strengths” and can be used to
help further facilitate positive changes (King et al., 2021). In this project, each unit already
contains USP <800> carts to be used when handling and administering HDs. Additionally, each
staff member on these units is required to complete an online module on safe handling and
administration of USP <800> HDs annually, that is frequently updated by Hospital A’s Quality
Improvement Team to ensure the most up-to-date information is being shared. Finally, Hospital
A’s EHR is already equipped with the technology to identify USP <800> HDs. Warning banners
both on the summary page of the patient’s chart and in the MAR are used to notify medical staff
about the medication and recommended PPE to use. The system can also monitor other local
EHR systems and will notify the staff member if the patient is on a HD, even if documented
outside Hospital A’s records. These strengths are a positive step in making change happen.
Weaknesses in this analysis include areas that may cause negative effects on the process
and delay the desired change (King et al., 2021). While USP <800> carts are available on each
unit, they are not utilized due to decreased knowledge of the cart, stocking inconsistencies, and
no personnel responsible for maintenance or upkeep. Additionally, the warning banners in the
EHR and MAR were found to fire but not list specific PPE recommended or the concerning
medication making it difficult to eliminate risks. Finally, although available on the unit, room
and bathroom door signs are rarely utilized or posted.
Opportunities and Threats. Opportunities involve future areas of improvement that are
achievable within the microsystem (King et al., 2021, p 179). In this project, the opportunities
should increase compliance of USP <800> guidelines. Appointing a responsible staff member to
regularly check and restock USP carts can increase accessibility and the likelihood that nurses
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will use the carts regularly. Finally, future opportunities exist for door signage such as reviewing
signage during shift rounding or by a responsible staff member like a unit secretary or charge
nurse.
Threats in the SWOT analysis take into consideration the potential risks or hazards that
may arise within the facility while implementing the project (King et al., 2021). It was
anticipated that factors such as lack of time or sustainability of cart maintenance or sign
verification could impede the change project. Additionally hiring and training new staff members
may require extra resources that will be taken away with the implementation of the project.
Finally, as USP <800> standards and policy change, personnel will be needed to identify,
implement, and educate the staff about the new change.
Plan-Do-Study-Act (PDSA) Cycle. The PDSA cycle is a tool used in improvement
projects to evaluate the effectiveness of the change and determine if the anticipated objective is
met or if the plan must be altered to achieve the goal (Finkelman, 2019, p.84) and can be viewed
in Appendix G. The cycle is cyclical, easily allowing for changes to be made to obtain the best
outcome possible. The PDSA cycle in this improvement project occurred over 13 weeks as seen
in the Gantt chart in Appendix H.
Plan. The initial “plan” phase begins the first day of the project and involves creating a
global and specific AIM statement. After several meetings with Hospital A’s staff, a PICOT
question was developed, and a plan of action was constructed. Research was completed to
determine the current standard practice for safe handling and administration of HDs. Data
collection forms and questionnaires were created based on standard practice and current
protocols at Hospital A. The microsystem was analyzed using the 5 P’s framework to determine
the purpose of the microsystem, typical patient population, the involved medical professionals,
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and the current processes and patterns within the microsystems (King & Gerard, 2016). Once the
microsystem is assessed and the possible concerns were identified, a SWOT analysis and a root
cause analysis (RCA) are conducted to evaluate the possible causes (King & Gerard, 2016).
Specifically in this project an Ishikawa (fishbone) diagram was created to determine a list of
potential sources that could lead to decreased compliance of safe handling and administration of
USP <800> HDs (seen in Appendix I). This process took seven weeks.
Do. The next step is the “do” phase where implementation of the plan occurs. Data
collection occurred over a two-week period on two units at Hospital A’s two campus locations
using both active and passive observation techniques. The EHR was initially assessed to
determine the HD and recommended precautions. Next, observations about signage were
gathered and the location and supplies in the USP <800> carts were noted. On each day of data
collection, at least one nurse from each unit was surveyed using an ‘elbow-to-elbow’ technique
to determine a baseline of understanding and knowledge of HD administration (questionnaire in
Appendix J). Finally, passive observations about PPE donning and doffing procedures were
noted if witnessed during data collection.
Study. The third step of the PDSA cycle is “study” which entails analyzing the collected
data and reviewing the results. The analysis of the data can be seen in the Results section. This
step of the cycle took three weeks to complete.
Act. The fourth and final step is the ‘act’ phase where the findings are compared with the
expected results to see if the change achieved the desired goal. If the goal is not accomplished or
a better outcome is wanted, the plan of the PDSA cycle will be changed and the cycle will be
repeated until the anticipated objective is obtained. Due to the time constraints of this project,
only one PDSA cycle was completed and the recommendations about future changes were
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presented to Hospital A’s USP <800> Committee. The act phase took less than 2 weeks to
complete.
Intervention
The project took place on two medical-surgical units at an acute care hospital, Hospital
A, in the Greater Bay Area of Northern California. One unit is located at each of the hospital’s
two locations and historically had the highest number of patients given USP <800> HDs behind
the oncology units per an internal report produced by Hospital A’s pharmacy department. The
project started August 2022 and ended December 2022 with a data collection period between
October 17, 2022 and October 28, 2022. An International Review Board (IRB) evaluation was
completed (see Appendix K) but pre-approval was not required due to the nature of the QI
project.
Hospital A’s two units were visited once daily Monday through Friday during the data
collection period. The EHR was first evaluated for the number of patients on USP <800> HDs
using a preprogrammed icon on the patient dashboard. Each chart was opened and reviewed for
the name of the hazardous medication, type of risk associated with the medication, and
description of the precautions necessary. The bedroom and bathroom doors in these patient’s
rooms were examined to determine if proper signage was posted and completed per Hospital A’s
policy (see Appendix D & Appendix E).
All units at Hospital A contain at least one HD cart that contains the necessary materials
to handle and administer the medications as well as clean spills and bodily fluids. The carts
should contain the following ten items: medication crush, gloves, isolation gowns, chemotherapy
gowns, goggles, face shield, bleach wipes, Sani-Wipes, a spill kit, and laminated HD PPE chart
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resource guide. The carts were examined daily for the number of correct items on each cart and
the location of the cart(s) were noted.
Due to increasing survey fatigue in the workplace, a survey was performed by an
informal ‘elbow to elbow’ conversation where the data collectors asked at least one nurse on
each unit during the daily visits questions to analyze the current understanding and proper
compliance of safe handling and administration of HDs. Results were recorded on a previously
created form (see Appendix J). Finally, during each visit, passive observation of PPE donning
and doffing techniques were assessed following Hospital A’s tip sheet in Appendix C.
The CNL and team then analyzed the quantitative and qualitative data collected from the
observations and the anonymous questionnaires to determine the knowledge of current standards
performed on the units. The findings of the project will be presented to Hospital A’s USP <800>
Committee including recommendations on how to improve compliance and limit future risks.
Study of Intervention
The measurement strategies in this QI project included observation and surveys using an
informal interview approach. Active observation, also known as active participation, occurs
when an observer is openly involved in the recipient’s situation and uses tactics like watching,
listening, clarifying, and instructing to improve the behavior or outcome (KU School of
Medicine, n.d.). Passive observation is when the observer does not interact to the situation with
the goal of observing the recipient’s true behaviors. Active observation was utilized when
interviewing the nurses about their understanding and compliance with USP standards. Passive
observation was the most frequent method used such as to determine if the door signs were
appropriately posted and while watching the donning and doffing of PPE.
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To assess the quantitative data including the number of patients on HDs and the average
number of supplies on the USP cart, a Google Form was created using various question types
such as checklists and fill-in-the-blanks to collect the pertinent data. Qualitative data was also
collected on the Google Form through an open-ended long answer text format.
Finally, a separate questionnaire was completed on a Google Form to document the answers
to the questions from ‘elbow-to-elbow’ discussions with nurses (see Appendix J). Question types
included rating processes or knowledge on a scale of one to ten (identifying what the number
sequence on the scale represents), quantitative questions like estimating the number of times one
administers HDs weekly, qualitative questions like knowing the location of specific items, and
utilization of the Likert Scale for frequency estimations.
Measures
According to Harris et al. (2018), the basis for quality improvement involves choosing
clear and well thought out measurements and metrics to properly identify change. The outcome
measure in this project is improvement in overall compliance of the USP <800> protocols.
Various factors need to be considered including calculating percentages of correct door signage,
averaging the correct number of supplies in each unit’s USP cart, assessing the number of correct
PPE donning and doffing occurrences, evaluating the accessibility and practicality of the EHR,
and determining the current knowledge and understanding of Hospital A’s USP <800> policy
and procedures.
The number of accurate door signs was calculated by finding the percentage of
appropriate signage for each unit and combining them to find Hospital A’s overall compliance
rate. During each day of data collection, the number of correct supplies on each PPE cart were
counted and documented. Since each cart should have ten different supplies, the number of
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correct supplies was divided by ten. The averages for each unit were calculated depending on the
number of carts present and multiplied by 100 indicating the percentage of accurate supplies on
the carts. Donning and doffing occurrence were documented as either “Yes” indicating a correct
procedure or “No” meaning it was done incorrectly. The “Yes” findings were divided by the total
number of occurrences observed to find the percentage of times the procedure was done
correctly. Accessibility and practicality of the EHR was determined by assessing how often the
banner PPE recommendations matched the medication listed in the MAR. Finally, the staff’s
current knowledge of USP <800> was determined using a survey seen in Appendix J.
Ethical Considerations
This project is classified as a QI project (Dang et al., 2021). It was approved by the
School of Nursing and Health Professions faculty at the University of San Francisco and is
associated with the master’s level CNL curriculum. Per the Statement of Determination and
Institutional Review Board (IRB) Statement of Non-Research Determination Form located in
Appendix K, this QI project does not meet the criteria needed for IRB pre-approval. Participation
during any portion of the data collection was voluntary and expectations were discussed and
acknowledged by participant prior to collecting data. Patient safety and confidentiality were top
priorities throughout the project. Healthcare workers who participated in surveys were asked to
participate prior to beginning the survey. Anonymity, confidentiality, transparency, and respect
were upheld during the entire project. This QI project did not receive any funding and no
conflicts of interests were detected.
The QI project was inspired by the Jesuit value of cura personalis, a highly respected
value of the Jesuit community and of the University of San Francisco (Our Mission and Values,
n.d.). This value emphasizes the importance of caring for all portions of the body equally
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including the body, mind, and spirit with respect and dignity (Our Mission and Values, n.d.).
Ensuring healthcare professionals and patients are properly protecting themselves and reducing
the risk of exposures to others parallels with this value. Furthermore, the American Nurses
Association’s (ANA) Code of Ethics (COE) helped guide this project by providing the ethical
responsibilities of nurses within the healthcare system. The ANA COE Provision 7.2 states it is
essential for nurses to “establish, maintain, and promote conditions of employment that enable
nurses to practice according to accepted standards” (Association & Hegge, 2015). This
emphasizes the importance of supporting the safety protocols and guidelines established by USP
to maintain a safe work environment. Not only does ANA COE state that nurses must “promote,
advocate, and protect the rights, health, and safety of the patient” in Provision Three, but also
acknowledges the importance of protecting the “health, safety, and well-being” of oneself in
ANA COE Provision Five (Association & Hegge, 2015). Overall, the nurse has the ethical
responsibility to promote a safe environment for all involved including the patient, visitors, all
healthcare workers including oneself, and the environment.
Section IV. Results
Results from this project showed that over a quarter (27.7%) of the patients on the units
at Hospital A were on at least one USP <800> HD over the data collection period (see Appendix
L). Each chart was evaluated for a MAR banner notifying staff which precautions to take. It was
found that the banner did not load any precautions 100% of the time. This result was reported to
the hospital’s IT department immediately for further investigation. In addition to noting the
MAR banner, each chart was inspected for the name and type of USP <800> medication. If the
USP icon and banner fired in the chart but the specific medication was not listed in the MAR, it
was considered a “misfire” of the icon. A “misfire” occurred 53 times meaning 30.6% of the
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patients did not have a known HD listed in the chart and therefore staff did not know what
precautions were necessary to reduce health risks.
Next, USP signage was observed and analyzed. It was determined that 13 of the 173
patients (7.5%) on the two units at Hospital A had correctly posted door signage on their room
door while only 3 of the 173 patients (1.7%) had a correctly posted bathroom door sign.
While gathering data on the two units, donning and doffing of PPE by various healthcare
workers was witnessed. Out of the 37 times donning and doffing was passively observed, 36
occurrences were done following proper protocol as seen in Appendix C. This means that 97% of
the time that PPE is worn, it is put on and taken off following the correct steps.
The USP <800> supply carts were also located and inspected daily on each unit. One unit
had a total of three carts located in a supply closet and the other unit had two carts with one cart
in each medication room. It was found that none of the carts were stocked properly at each
hospital. An average of the number of correctly located items were documented daily and the
trends can be seen in Appendix M. Additionally, some carts were also noted to have random
medical supplies like needles and syringes that do not need to be stocked in the carts. It was
noted that the carts appeared to be in the same locations each daily visit and therefore it was
hypothesized that the carts were never moved or were even utilized during the collection period.
When asked who restocks the carts or orders the supplies, various healthcare workers on the
units did not know.
Finally, an ‘elbow-to-elbow’ discussion was conducted with on-duty nurses and the
questionnaire (seen in Appendix J) was completed by the research team at the end of the
conversation. A total of 27 nurses were surveyed on the units of Hospital A and to limit bias,
each nurse was assured the questionnaire answers and the conversations would be kept
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completely confidential. The questions and answers to the questionnaire are displayed in
Appendix N. Nurses reported an average knowledge of USP <800> HDs as 7.15 on a scale from
one to ten (one indicating no knowledge and ten indicating a high level of knowledge). On a
similar scale from one to ten (one indicating not feeling comfortable and ten indicating very
comfortable), it was reported that nurses have an average of 8.45 of comfortability with handling
USP <800> HDs. When asked how often they administer HDs per week, there was a large range
of answers from zero times per week up to fifteen times per week but overall reported an average
of 3.44 times per week. In terms of locations of USP <800> carts and waste receptables, fifteen
nurses reported knowing their locations while ten reported not knowing where they were located
on the unit. Using another scale from one to ten (one indicating very difficult with ten indicating
very easy), nurses were asked to rate how easy they felt it was to identify proper signage and
recommended PPE and an average of 8.39 was reported. Finally, nurses were asked about how
often they followed the recommended PPE while handing and administering USP <800> HDs:
Twelve nurses reported ‘always’ wearing the correct PPE, ten reported ‘sometimes’ wearing
correct PPE, four nurses reported ‘most of the time’, and one nurse reported ‘never’ wearing the
recommended PPE.
Section V. Discussion
Summary
Due to updates in current standards, improvements in care, and advances in technology,
the healthcare community is constantly changing and adapting to provide high-quality, evidencebased care to all patients. To effectively endorse change, a current standard of practice must be
established before changes can be made. This QI project used observation, surveys, and
assessments to establish a baseline of current knowledge and compliance of USP <800> HD

USP <800> COMPLIANCE

27

standards in two units at Hospital A. It was determined that while nurses had a strong
understanding of safe practice, the techniques and procedures were not always followed for a
variety of reasons creating a frequent and unnecessary health risk to the patient, visitors,
healthcare workers, and the environment.
Limitations
This QI project had several limitations. First, the data collection period was only two
weeks long and data was only collected from day-time nurses. Due to the high demand and busy
workflow of the on-duty nurses, only a limited number of nurses were surveyed leading to few
data points to analyze. Next, the surveys were self-reported meaning the findings are based on a
nurse’s subjective understanding and knowledge of the USP <800> standards. As found in many
research studies like Colvin (2016), self-reported survey responses often express a higher level of
adherence to a policy compared to the action being observed. This likely means compliance and
knowledge is lower than survey results found. Some of the survey questions also required
qualitative answers which can be difficult to effectively analyze. Finally, although over a quarter
of the patients on the two units were on USP <800> HD precautions, the medications were
generally not administered daily so observation of physical administration of a HD was
infrequent.
Conclusion
This QI project sets the groundwork for many future projects at Hospital A. The findings
showed that while nurses report an understanding of USP <800> HD safety, healthcare personnel
are not always following the appropriate precautions to reduce risk to themselves, the patient,
other healthcare workers, and the environment. The following three recommendations were
made to Hospital A to improve hazardous risks.
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First, repairing and improving technological glitches can help increase awareness among the
healthcare team. Although a warning banner was attached to the appropriate charts, due to a
technical error the banner did not give appropriate PPE recommendations. Additionally, 31% of
the charts did not list an active USP <800> medication leading to confusion about what
precautions to take. Fixing these technological issues will likely encourage compliance.
The second recommendation involves restocking USP <800> carts. Currently there is no set
person to do this task leading to it not being done. A staff member noted that a centralized
location with signs, a checklist, and all supplies needed for proper handling and administration of
USP <800> medications would simplify the current barriers and promote safe techniques by
acting as a “grab and go” area. Since the unit secretary at Hospital A already has the
responsibility of maintaining the supply stock and ordering supplies as needed, this would be a
good assignment to add to this role.
The third and final recommendation includes establishing a method to routinely assess
door signage for each patient on a USP <800> HD. On admission to the unit or when the HD is
ordered, the chart should add a section to report if proper PPE signage is posted on the patient’s
bedroom and bathroom doors similar to documenting if the bed is in the lowest position and if
suction devices are present in the room. It is recommended to assign responsibility to the charge
nurse who will check if signs are posted and contain the correct information each day. The
questionnaire revealed that nurses felt like they did not have enough time to create and post the
signs but instead relied on the banner in the MAR and medication labels to comply with proper
PPE requirements. However, non-nursing staff like housekeeping reported not having the proper
signage on the doors makes it impossible for them to know about the risks of the HDs and are
therefore unable to protect themselves.
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Cost is a major factor and common barrier in implementing QI projects and executing the
recommendations. A cost-benefit analysis incorporating the above recommendations reveals
even with extra supplies required and additional duties added to current positions, the hospital
will save a significant amount of money annually. The detailed cost analysis is available in
Appendix O. The average cost for restocking the PPE required is estimated to be $25,000
annually but majority of these costs are already being spent by the hospital as PPE is being worn
but is not located in centralized location specifically for HD administration. The above
recommendations are also estimated to increase PPE usage causing a rise in the annual PPE
budget. Per Glassdoor (2022), the average hourly wages in California for unit secretary is
$21.49, for a RN Charge Nurse is $70.32/hour, and for a EHR IT Analyst is $55.00/hour.
According to the U.S. Department of Labor, the average workers’ compensation cost for one
instance of injury or illness due to hazardous drug exposure is $57,292 (Workers' Compensation,
n.d.). Based on the estimated costs, it was concluded that $8,413.85 would be saved if the
proposed recommendations prevented just one workers’ compensation claim annually. Each
additional prevented claim would save $57,292 of expenditure annually.
As the USP <800> list continues to grow with more awareness and advances in medicine,
appropriate healthcare staff education about proper compliance will be needed to ensure the
safety of patients, healthcare employees, and the environment. This clinical intervention reveals
the importance of observation and frequent assessments to help identify and mitigate barriers
within the microsystem and the importance of complying with USP <800> standards to reduce
unnecessary and preventable risk of HD exposures.
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Section VII. Appendices
Appendix A
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• Participants
took a survey
about rate of
HD handling,
training, and

• n = 103
healthcare
employees
• Canadian
Healthcare
System: five
acute care
sites and one
cancer
treatment
center
8 job categories
evaluated: unit
clerk,
pharmacist,
pharmacy
receiver,
pharmacy

USP <800> guidelines
are not regulated by
USP but can be enforced
by federal or state
agencies
Despite protocols to
JHNEBP:
reduce risk, healthcare
Level I
workers are still exposed A
regularly to HD
No correlation found
between urine
concentrations of CP
and known contact
during shift
Workers who do not
have direct exposure to
handling HDs were
found to have the
highest level of CP in
urine samples

Limitation:
Study did not
include
housekeeping
who may have
the greatest
potential
exposure risk
Surveys were
self-reported and
not verified for
accuracy

USP <800> COMPLIANCE
known contact technician,
of HD on shift porter, nurse,
transport, other
(volunteer,
oncologist,
dietician)

39
Two factors associated
with substantial CP:
1. Worker who
handling HDs
regularly as job
2. Workers without
proper HD
training
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Appendix B
PPE Workflow Diagram
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Appendix C

Hospital A’s Tip Sheet for Proper Donning & Doffing Techniques

Hazardous Drug Tip Sheet: PPE Donning and Doffing
Proper donning and doffing of PPE is an important way to maximize protection and minimize exposure to
hazardous materials. Take a moment to review the correct donning and doffing order. These instructions are
also posted on the hub.

Tip Sheet sourced from John Muir Health

For questions or concerns regarding hazardous medications or reproductive toxins, reach out to the pharmacy,
your PDS, or consult the Pharmacy Hub Page
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Appendix D

Precaution Sign for Patient’s Room Door

HAZARDOUS DRUG PRECAUTIONS
Start Date _________

End Date___________
Or Continuous

Precaution Level (circle one)
Precaution
Level

Label

HAZARDOUS

RED

HAZARDOUS:
LIMITED RISK

GREEN

REPRODUCTIVE
TOXIN
(Only applies to
personnel with
reproductive
concerns)

YELLOW

Red

Administration Route/ Handling Activity

Green
ASTM
D6978
Certified
Gloves

Yellow

Gown Type

Eye &
Face
Protection

Respiratory
Protection

-Intravenous, Intramuscular, Subcutaneous,
Intrathecal
-Oral: RISK of spitting, splash, splatter, or spray

Double
Glove

Chemo

If high
splash risk

None

Topical dosage form

Double
Glove

Chemo

If high
splash risk

N95
(If inhalation
potential)

Double
Glove

Chemo

Yes

None

Double
Glove

Chemo

Yes

N95 or
PAPR†

Single
Glove

Body Fluids/Waste containing trace medication
or metabolites (e.g. emesis, urine, stool)
-Intravesicular, Intraperitoneal, Irrigation,
Aerosol Inhalation
-Spill of hazardous medication: Contact Veolia
when >5 mL
Oral: LIMITED TO NO RISK of spitting, splash,
splatter, or spray

None

None

None

Oral: RISK of spitting, splash, splatter, or spray

Double
Glove

Chemo

If high
splash risk

None

Body Fluids/Waste Containing trace medication
or metabolites (e.g. emesis, urine, stool)

Double
Glove

Chemo

Yes

None

None

-Intravenous, Intramuscular, Subcutaneous,
Intrathecal
-Oral: RISK of spitting, splash, splatter, or spray.

Double
Glove

Standard
Isolation

If high
splash risk
Only face
shield

Oral: LIMITED TO NO RISK of spitting, splash,
splatter, or spray

Single
Glove

None

None

None

Crushing

Double
Glove

Standard
Isolation

None

None (if
ENFit Pouch
is unavailable
don N95)

-Intravesicular, Intraperitoneal, Irrigation,
Aerosol Inhalation
-Spill of reproductive toxin medication

Double
Glove

Standard
Isolation

Only face
shield

N95

Topical dosage form

Double
Glove

Standard
Isolation

Body Fluids/Waste Containing trace medication
or metabolites (e.g. emesis, urine, stool)

Double
Glove

Standard
Isolation

If high
splash risk
Only face
shield
If high
splash risk
Only face
shield

NOTE: For all activities that are not designated high splash risk, wear eye and face protection if desired.

Observe Precautions PO Drugs 7 days and ALL OTHER ROUTES 48 hours

Sign sourced from John Muir Health

N95
(If inhalation
potential)

None
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Appendix E
Precaution Sign for Bathroom Door

HAZARDOUS DRUG PRECAUTIONS
POST ON BATHROOM DOOR

Precaution Level
Reproductive Toxin

Red/Green

Yellow

Hazardous/Limited Hazardous

(For staff with reproductive concerns only)

Double glove

Double glove

Standard isolation gown

Chemo gown

If high splash risk, face shield

If high splash risk, goggle and face shield

All PPE disposed of in Regular Trash Bin

All PPE and saturated or flaking linens
disposed of in Regular or Large Yellow Bin

All linens follow routine management

Linen which is not saturated or flaking with
bodily fluids is to be placed in yellow linen bag

Toilet is to be double flushed after any bodily fluid disposal,
place chux over toilet while flushing.

Sign sourced from John Muir Health
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Appendix F
SWOT Analysis

Strengths

Weaknesses

• Hazardous carts available on the
units
• USP 800 training for staff
• Warning banners in each patient
MAR

• Some staff not using the carts
• Unit secretary not trained on USP
800
• No responsible person to fill the carts
• Warning banners misfiring
occasionally

Opportunities

S W
O T

• Assign responsible person to check
and refill the carts
• Daily door signage rounding
• Increased compliance with USP 800
Federal guidelines

Threats

• Lack of sustainability
• Training for new staff members
• Maintenance and replacement of
carts
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45
Appendix G
PDSA Cycle

This PDSA is for the first cycle of the change project.
PLAN
ACT
●
●
●

Determine if desired goal was achieved
Develop next steps or recommendations
based on results
Results and Recommendations
Presented to Hospital A on 11/22/22

●
●
●
●
●
●
●

Analyze the microsystem using 5Ps
framework assessment
Collaborate with Hospital A
Develop a Global & Specific AIM
Develop a PICOT Question
Create data collection forms &
questionnaires
Conduct a root cause analysis (RCA)
Conduct a SWOT analysis

DO
STUDY
●
●

Analyze data gathered from:
○
Passive & Active Observations
○
‘Elbow-to-Elbow’ Questionnaires
Review results of data

●

Conduct data gathering on Med-Surg
units in Hospital A
■
Passive & Active observational
data collection
■
Administer ‘elbow-to-elbow’
questionnaires
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Appendix H
Gantt Chart
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Appendix I
Ishikawa Diagram (Fishbone Diagram)
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Appendix J

Nurse ‘Elbow-to-Elbow’ Questionnaire Forum
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Appendix K
Statement of Determination

Title of Project: United States Pharmacopeia (USP) <800> Standards: Increasing Compliance of
Safe Handling and Proper Administration of USP General Chapter <800> Drugs
Brief Description of Project
A. Aim Statement
To improve nurse compliance with administration and safe handling of
Hazardous Drugs (USP <800>) as outlined in the Hospital A 2022 Hazardous
Drugs (HD) Safe Handling and Management Updates Training through active
and passive observation on two medical surgical units by 50% within 1 month.
B. Description of Intervention
Interventions will include active and passive observation of hospital personnel
and the hospital environment and informal ‘elbow to elbow’ surveys between
clinical team and nurses.
C. How will this Intervention Change Practice?
This intervention and quality improvement project will determine current level
of knowledge and compliance among Hospital A’s staff to ensure safe and
proper handling and administration of USP <800> hazardous drugs. The results
can be used to establish a current baseline and help develop and shape future
staff education.
D. Outcome Measurements
• The total number of patient’s on USP <800> hazardous drugs on the units.
• The number of appropriate EHR alert notices.
• The number of currently documented door signs and bathroom door signs.
• The number of currently witnessed PPE donning and doffing occurrences.
• An estimated number of correct supplies located on designated USP <800>
PPE carts along with the location of these carts.
• An information ‘elbow-to-elbow’ questionnaire with nurses to determine:
o Current Knowledge of USP <800>
o Comfortability with handling and administration of USP <800> HD
o Number of times per week each nurse administers the drugs
o Knowledge of location of USP <800> carts and waste receptacles
o Ease of identification of patients on HDs including documentation
of signage and difficulty to determine recommended PPE
o How often nurses follow recommended PPE
To qualify as an Evidence-based Change in Practice Project, rather than a Research Project, the
criteria outlined in federal guidelines will be used: (http://answers.hhs.gov/ohrp/categories/1569)
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This project meets the guidelines for an Evidence-based Change in Practice Project as outlined in
the Project Checklist (attached in Comments). Students may proceed with implementation.
Comments:
IRB Statement of Non-Research Determination Form:
EVIDENCE-BASED CHANGE OF PRACTICE PROJECT CHECKLIST *
Project Title:
Y E SN O
The aim of the project is to improve the process or delivery of care with established/
accepted standards, or to implement evidence-based change. There is no intention of using X
the data for research purposes.
The specific aim is to improve performance on a specific service or program and is a part
of usual care. ALL participants will receive standard of care.

X

The project is NOT designed to follow a research design, e.g., hypothesis testing or group
comparison, randomization, control groups, prospective comparison groups, crosssectional, case control). The project does NOT follow a protocol that overrides clinical
decision-making.

X

The project involves implementation of established and tested quality standards and/or
systematic monitoring, assessment or evaluation of the organization to ensure that existing
quality standards are being met. The project does NOT develop paradigms or untested
methods or new untested standards.

X

The project involves implementation of care practices and interventions that are
consensus-based or evidence-based. The project does NOT seek to test an intervention
that is beyond current science and experience.

X

The project is conducted by staff where the project will take place and involves staff who
are working at an agency that has an agreement with USF SONHP.

X

The project has NO funding from federal agencies or research-focused organizations and
is not receiving funding for implementation research.

X

The agency or clinical practice unit agrees that this is a project that will be implemented
to improve the process or delivery of care, i.e., not a personal research project that is
dependent upon the voluntary participation of colleagues, students and/ or patients.

X

If there is an intent to, or possibility of publishing your work, you and supervising faculty
and agency oversight committee are comfortable with the following statement in your
methods section.

X

ANSWER KEY: If the answer to ALL of these items is yes, the project can be considered an
Evidence-based activity that does NOT meet the definition of research. IRB review is not
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required, except at Stanford Hospital. Keep a copy of this checklist in your files. If the answer to
ANY of these questions is NO, you must submit for IRB approval.
*Adapted with permission of Elizabeth L. Hohmann, MD, Director and Chair, Partners Human
Research Committee, Partners Health System, Boston, MA.
Signature of Supervising Faculty_________________________
Signature of Student: Katelyn Sinclair

Date: 10/03/22
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Appendix L

Chart with Number of Patients on USP <800> Drugs

Patients of USP <800> Hazardous Drugs
700

600

500

452

400

300

200

252

200

100

71

102

172

0
Unit A
Number of Patients on USP <800>

Unit B

Combined

Number of Patients NOT on USP <800>
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Appendix M

Average Number of Supplies on USP <800> Carts

Average Number of Supplies Per USP <800> Cart
100%
90%
80%
70%
60%
50%
40%
30%
20%
10%
0%
10/17/2210/18/2210/19/2210/20/2210/21/2210/24/2210/25/2210/26/2210/27/2210/28/22
Total Desired Supplies
Average Number of Supplies Per Cart - Unit B
Average Number of Supplies Per Cart - Unit A
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Appendix N
Nurse Questionnaire Results
Nurse Questionnaire

Hospital A
{27 Nurses}

On a scale of 1-10, how would you rate your knowledge of Hazardous Drugs
(USP <800>) (1 indicating no knowledge, 10 indicating a high level of
knowledge)?

Mean: 7.15

On a scale of 1-10, how comfortable do you feel with the handling of Hazardous
Drugs (USP <800>) (1 indicating not comfortable at all, 10 indicating very
comfortable)?

Mean: 8.45

How many times per week do you administer Hazardous Drugs (USP <800>)?

Mean: 3.44

Do you know where the Hazardous Drugs (USP <800>) carts and waste
receptacles are located?

Yes: 16
No: 11

On a scale of 1-10, how easy do you feel it is to identify Hazardous Drugs (USP
<800>) signage and recommended PPE for administration of the drugs?

Mean: 8.39

How often do you follow the Hazardous Drugs (USP <800>) PPE
recommendations?

Always: 12
Sometimes: 10
Most of the
Time: 4
Never: 1
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Appendix O
Cost-Benefit Analysis
Annually
Cost

Cost: Items

Cost: Duties

Restocking Supplies (PPE)
USP <800> Signage
Unit Secretary
• Salary: $21.49/hour
• Expected Extra Hours Per Week: 2
$21.49 x 2 = $42.98 / week
$42.98 x 52 weeks = $2234.96
Charge Nurse
• Salary: $70.32/hour
• Expected Extra Hours Per Week: 5
$70.32 x 5 = $351.60 / week
$351.60 x 52 weeks = $18283.20
IT Analyst: EHR
• Salary: $55.00/hour
• Expected Extra Hours Per Week: 1
$55.00 x 52 weeks = $2860

Worker’s
Compensation
Claim

Total Cost

$25,000
$500

$2,234.96
$48,878.15
$18,283.20

$2,860.00

$57,292 per
claim

Total Saving Annually for One Workers' Compensation Claim:

-($57,292)
$8,413.85

